ANN ARBOR, Mich., Dec. 12 /PRNewswire/ -- Terumo Corporation and Terumo's subsidiary, Terumo Cardiovascular Systems Corporation, announced today that they have entered into an agreement to settle all outstanding litigation with Maquet Cardiovascular, LLC. The companies have a number of lawsuits pending in which each claims the other has infringed its patents. The litigations all involve methods and devices used in endoscopic vessel harvesting. All pending disputes between the companies will be immediately dismissed. In addition, the companies have agreed to cross license certain patents.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061027/DEF004LOGO )
Terumo Corporation is a global health care company dedicated to research, development, manufacturing and marketing of medical products and equipment with a focus on the treatment of cardiac and vascular disease. For more information, please visit www.terumo.com.
Terumo Cardiovascular Systems Corporation is a global manufacturer and marketer of medical devices for cardiac and vascular surgery. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; Ashland, Massachusetts; and Tustin, California. For more information, visit www.terumo-cvs.com.
Forward-looking statements included in this release were determined by the companies based on the best information available at the time of writing and are subject to potential risks and uncertainties. Therefore, please note that, due to various factors, the actual implementation may differ from what is described here.
CONTACT: Barbara Schmid, Director, Corporate Communications, Terumo
Cardiovascular Systems, +1-734-741-6362, +1-734-657-6860 (cell),
barbara.schmid@terumomedical.com
Web site: http://www.terumo-cvs.com/
http://www.terumo.com/
